Conveners
Session 13 - Clinical MR-PET
- Irene Neuner (JARA Brain)
Ms
Kimberly Jackson
(Center for Biomedical Imaging, Department of Radiology, NYU Langone Medical Center, New York, NY USA)
5/20/15, 6:00 PM
7 - Clinical MR-PET
Talk
Background: Dixon-based MR is acquired for attenuation correction of brain PET during PET/MR. Early adopters of PET/MR have noted variability in the performance of Dixon-based tissue segmentation, and questions exist regarding potential impacts on quantitative accuracy in dual-time-point studies.
Methods: Ten patients injected with 10 mCi FDG underwent dual-time-point clinical brain...
Dr
Maged Goubran
(Stanford University), Dr
Michael Zeineh
(Stanford University)
5/20/15, 6:20 PM
7 - Clinical MR-PET
Talk
Alzheimer’s disease (AD) has been reported to show decreased metabolic activity in the hippocampus using FDG PET-MR. Histological data suggests that the hippocampal subfields are selectively affected in AD. Given the simultaneous imaging nature of integrated PET-MR scanners and the multimodal capabilities of PET-MR, our purpose here is to assess FDG activity, as well as ASL perfusion in the...
